Pazopanib hydrochloride CAS 635702-64-6
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
635702-64-6
Name
Pazopanib hydrochloride
Synonyms
5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide hydrochloride (1:1) [ACD/IUPAC Name]
5-({4-[(2,3-Diméthyl-2H-indazol-6-yl)(méthyl)amino]-2-pyrimidinyl}amino)-2-méthylbenzènesulfonamide, chlorhydrate (1:1) [French] [ACD/IUPAC Name]
5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzolsulfonamidhydrochlorid (1:1) [German] [ACD/IUPAC Name]
635702-64-6 [RN]
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1) [ACD/Index Name]
GW786034B
GW-786034B
Pazopanib Hydrochloride [USAN]
Votrient [Trade name]
[635702-64-6]
444731-52-6 [RN]
5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide hydrochloride
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride
5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride
5-[[4-[(2, 3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2- methylbenzenesulfonamide;hydrochloride
5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide hydrochloride
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide and hydron and chloride
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide HCl
5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide hydrochloride
Armala
GW 786034
GW786034
GW786034;Votrient;Armala;GW 786034;GW-786034
GW786034GW786034, VOTRIENT
HYDROGEN PAZOPANIB CHLORIDE
MFCD12546138 [MDL number]
Pazopanib
Pazopanib (GW-786034)
Pazopanib (Hydrochloride)
Pazopanib HCL
Pazopanib HCl (GW786034 HCl)
pazopanib monohydrochloride
Pazopanib, Votrient, GW786034B, GW 786034, GW-786034
UNII:33Y9ANM545
UNII-33Y9ANM545
Molecular Structure
SMILES
Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C.Cl
StdInChI
InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H
StdInChIKey
MQHIQUBXFFAOMK-UHFFFAOYSA-N
Molecular Formula
C21H23N7O2S.HCl
Molecular Weight
473.98
Properties
Appearance
White to off-white powder
Safety Data
WGK Germany
3
Specifications and Other Information of Our Pazopanib hydrochloride CAS 635702-64-6
Standard
Enterprise standard
Identification Methods
HPLC,XRD
Purity
99%min
Heavy Metals
10 ppm max
Loss on Drying
0.5% max
Residue on Ignition
0.2% max
Single Impurity
0.2% max
Total Impurities
0.5% max
Package
According to customer requirements to packaging
Manufacturing Capacity
KG Scale
Storage
Under room temperature away from light
Application
Palazepine Hydrochloride is a novel type of oral angiogenesis inhibitor that can interfere with the angiogenesis required for the survival and growth of stubborn tumors, targeting the role of vascular endothelial growth factor receptor (VEGFR), by inhibiting the new blood supply to the tumor Angiogenesis and work. Suitable for the treatment of advanced renal cell carcinoma (a type of renal cell carcinoma found in renal tubules), soft tissue sarcoma (STS), epithelial ovarian cancer and non-small cell lung cancer (NSCLC).
General View of Documents
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/pazopanib-hydrochloride-cas-635702-64-6/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/pazopanib-hydrochloride-cas-635702-64-6/